Trial Profile
Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2020
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary) ; Ranibizumab (Primary) ; Gatifloxacin
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 12 Mar 2018 New trial record